These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 24121190)
1. The treatment of melanoma brain metastases before the advent of targeted therapies: associations between therapeutic choice, clinical symptoms and outcome with survival. Vecchio S; Spagnolo F; Merlo DF; Signori A; Acquati M; Pronzato P; Queirolo P Melanoma Res; 2014 Feb; 24(1):61-7. PubMed ID: 24121190 [TBL] [Abstract][Full Text] [Related]
7. A statistical comparison of prognostic index systems for brain metastases after stereotactic radiosurgery or fractionated stereotactic radiation therapy. Rodrigues G; Gonzalez-Maldonado S; Bauman G; Senan S; Lagerwaard F Clin Oncol (R Coll Radiol); 2013 Apr; 25(4):227-35. PubMed ID: 23218874 [TBL] [Abstract][Full Text] [Related]
8. Treatment of melanoma brain metastases: a new paradigm. Carlino MS; Fogarty GB; Long GV Cancer J; 2012; 18(2):208-12. PubMed ID: 22453023 [TBL] [Abstract][Full Text] [Related]
9. Linear accelerator based stereotactic radiosurgery for melanoma brain metastases. Bernard ME; Wegner RE; Reineman K; Heron DE; Kirkwood J; Burton SA; Mintz AH J Cancer Res Ther; 2012; 8(2):215-21. PubMed ID: 22842364 [TBL] [Abstract][Full Text] [Related]
10. Intracerebral metastases of malignant melanoma and their recurrences--a clinical analysis. Miller D; Zappala V; El Hindy N; Livingstone E; Schadendorf D; Sure U; Sandalcioglu IE Clin Neurol Neurosurg; 2013 Sep; 115(9):1721-8. PubMed ID: 23643143 [TBL] [Abstract][Full Text] [Related]
11. Stereotactic radiosurgery in the management of brain metastases: an institutional retrospective analysis of survival. Frazier JL; Batra S; Kapor S; Vellimana A; Gandhi R; Carson KA; Shokek O; Lim M; Kleinberg L; Rigamonti D Int J Radiat Oncol Biol Phys; 2010 Apr; 76(5):1486-92. PubMed ID: 19619958 [TBL] [Abstract][Full Text] [Related]
12. Prognostic factors for stereotactic radiosurgery-treated patients with cerebral metastasis: implications on randomised control trial design and inter-institutional collaboration. Gonda DD; Kim TE; Goetsch SJ; Kawabe T; Watanabe S; Alksne JF; Hattangadi JA; Nitta M; Ott K; Hodgens DW; Carter BS; Yamamoto M; Chen CC Eur J Cancer; 2014 Apr; 50(6):1148-58. PubMed ID: 24529832 [TBL] [Abstract][Full Text] [Related]
13. Stereotactic radiosurgery for patients with "radioresistant" brain metastases. Brown PD; Brown CA; Pollock BE; Gorman DA; Foote RL Neurosurgery; 2002 Sep; 51(3):656-65; discussion 665-7. PubMed ID: 12188943 [TBL] [Abstract][Full Text] [Related]
14. Radiosurgery for brain metastases from primary lung carcinoma. Hoffman R; Sneed PK; McDermott MW; Chang S; Lamborn KR; Park E; Wara WM; Larson DA Cancer J; 2001; 7(2):121-31. PubMed ID: 11324765 [TBL] [Abstract][Full Text] [Related]
15. Prognostic factors for survival after stereotactic radiosurgery vary with the number of cerebral metastases. DiLuna ML; King JT; Knisely JP; Chiang VL Cancer; 2007 Jan; 109(1):135-45. PubMed ID: 17133440 [TBL] [Abstract][Full Text] [Related]